Such observations could be explained by a strong correlation between low systemic IL-10 levels and hyperinsulinemia and insulin resistance or by impaired suppressive activity of regulatory T cells in insulin-treated T2D pregnant women and in women with GDM [53, 54]. The gene discussed is IL10; the disease is Hyperinsulinemia.